Arcellx Inc (ACLX) USD0.001

Sell:$114.77Buy:$114.80Price increased$0.02 (0.02%)

NASDAQ:Price increased0.18%
Market closed |
Prices delayed by at least 15 minutes

Sell:$114.77
Buy:$114.80
Change:Price increased$0.02 (0.02%)
Deal now
Market closed |
Prices delayed by at least 15 minutes

Sell:$114.77
Buy:$114.80
Change:Price increased$0.02 (0.02%)
Market closed |
Prices delayed by at least 15 minutes

Deal now

Key metrics

Open$114.75
Previous close$114.75
Market cap$6.71bn
P/E ratio-99999.99
Volume584,202
Dividend yield0.00%
EMS-

Company information

Arcellx Inc. is a clinical-stage biotechnology company reimagining cell therapy by engineering immunotherapies for patients with cancer and other incurable diseases. Its lead program is a BCMA-targeting ddCAR product ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue58.48m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.